EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Visual fields in glaucoma: Where are we now?

Graham A Lee iD, George Y X Kong, Chun-Huei Liu

Clinical & Experimental Ophthalmology · 2023-03 · 51 (2) · 162-169

DOI: 10.1111/ceo.14210 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical & Experimental Ophthalmology, online erschienen am 16.02.2023. Verfasst von Graham A Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: City Eye Centre, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: COVID-19, Glaucoma. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Visual fields are an integral part of glaucoma diagnosis and management. COVID has heightened the awareness of the potential for viral spread with the practice of visual fields modified. Mask artefacts can occur due to fogging of the inferior rim of the trail lens. Fortunately, the risk of airborne transmission when field testing is low. The 24‐2c may be useful to detect early disease and the 10‐2 more sensitive to detect advanced loss. The SITA faster test algorithm is able to reduce testing time thereby improving clinic efficiency, however, may show milder results for moderate or severe glaucoma. The technician has an important role of supervising the visual field performance to achieve reliable output. Home monitoring can provide earlier detection of progression and thus improve monitoring of glaucoma as well as reduce the burden of in‐clinic assessments. Artificial Intelligence has been found to have high sensitivity and specificity compared to expert observers in detecting field abnormalities and progression as well as integrating structure with function. Although these advances will improve efficiency and guide accuracy, there will remain a need for clinicians to interpret the results and instigate management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19GlaucomaHumansVisual FieldsVisual Field TestsArtificial IntelligenceAlgorithmsVision Disorders

Stichwörter der Autor:innen

COVID-19artificial intelligencehome monitoringvisual fieldvisual field evaluation

Autor:innen und Institutionen

  • City Eye Centre, Brisbane, Queensland, Australia.
  • University of Queensland, Herston, Queensland, Australia.
  • Department of Ophthalmology, Mater Hospital, Brisbane, Queensland, Australia.
  • Glaucoma Investigation and Research Unit, Royal Victorian Eye and Ear Hospital VIC, East Melbourne, Victoria, Australia.
  • Centre for Eye Research Australia, Royal Victorian Eye, and Ear Hospital, East Melbourne, Victoria, Australia.
  • Ophthalmology, Department of Surgery, The University of Melbourne, Parkville, Victoria, Australia.

ORCID-Profile: Graham A Lee

Zitieren

APA

Lee, G. A., Kong, G. Y. X., & Liu, C. H. (2023). Visual fields in glaucoma: Where are we now?. Clinical & Experimental Ophthalmology, 51(2), 162-169. https://doi.org/10.1111/ceo.14210

Vancouver

Lee GA, Kong GYX, Liu CH. Visual fields in glaucoma: Where are we now?. Clinical & Experimental Ophthalmology. 2023;51(2):162-169. doi:10.1111/ceo.14210

BibTeX
@article{Lee2023,
  author = {Lee, Graham A and Kong, George Y X and Liu, Chun-Huei},
  title = {Visual fields in glaucoma: Where are we now?},
  journal = {Clinical & Experimental Ophthalmology},
  year = {2023},
  volume = {51},
  number = {2},
  pages = {162--169},
  doi = {10.1111/ceo.14210}
}
Kostenlos starten →